MNQ 0.00% 0.0¢ minquest limited

Nice to see we are back again. Good be really good MT-LT...

  1. 13,333 Posts.
    lightbulb Created with Sketch. 93
    Nice to see we are back again. Good be really good MT-LT investment and can follow same path as RAP & MDR.

    Cost effective Pain assessment tool - A point of care App which utilises facial recognition technology to detect micro- expressions which are indicative of presence of pain.

    ePAT App is designed to allow pain assessments to be: § Simple § Accurate § Objective § Reproducible

    Opportunistic markets where there is a current need for ePAT technology, examples include: § Tele-Health Ø Support clinician remote patient assessments § Insurance Claims Ø Assisting in assessment of personal injury claims § Pharmaceutical Companies Ø Monitoring tool for clinical trials of pain relief drugs.


    ePAT vs Abbey Pain Scale
    Patients n = 40
    Assessments = 354
    Correlation coefficient = 0.90

    Fund is raised for near 2 years est budget and NO CR expected anytime soon.
    [email protected] were issued to raise $4.5M
    Out of 657m ; 213m (34%) are escrowed for 2 years


    Taking its time but this could proven to be another RAP. Patience is the key for MT-LT.
 
watchlist Created with Sketch. Add MNQ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.